future glp 1 drugs Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care Dozens of new obesity drugs
Description
Unimolecular multi-specific agonist peptides targeting multiple incretin pathways have emerged as promising therapeutic strategies for weight loss 7,8,18,19,20,21,22,23,24,25,26
Figure 27: Photograph of Sir James Black (1924-2010), credit: Lyall
If youre prescribed a weight loss GLP1 medication or a diabetes-related GLP-1 treatment, dont hesitate to explore savings options
Its ability to mimic the hormone glucagon-like peptide-1 (GLP-1) is crucial in regulating appetite and food intake
Moins frquents, mais plus graves : dshydratation, insuffisance rnale, calculs biliaires, pancratites et hypoglycmies
A landmark randomized controlled trial published in The Journal of Clinical Investigation provides concrete data on how significantly these medications affect fluid intake
